MMCM
ARKG icon

Murphy & Mullick Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Murphy & Mullick Capital Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$841 Hold
20
– – ﹤0.01% 642
2026
Q1 		$528 Hold
20
– – ﹤0.01% 655
2025
Q4 		$579 Hold
20
– – ﹤0.01% 661
2025
Q3 		$596 Hold
20
– – ﹤0.01% 641
2025
Q2 		$487 Hold
20
– – ﹤0.01% 641
2025
Q1 		$415 Hold
20
– – ﹤0.01% 636
2024
Q4 		$471 Buy
+20
New +$492 ﹤0.01% 625

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Murphy & Mullick Capital Management's ARKG Position: Q2 2026 in Review

Murphy & Mullick Capital Management held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 20 shares worth $841. The position accounts for ﹤0.01% of the portfolio, ranked #642.

Murphy & Mullick Capital Management first reported a position in ARKG in Q4 2024 and has held it in 7 quarters since. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Murphy & Mullick Capital Management held 20 shares of ARK Genomic Revolution ETF worth $841 as of Q2 2026.
  • Murphy & Mullick Capital Management left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Murphy & Mullick Capital Management's portfolio in Q2 2026, its #642 holding.
  • Murphy & Mullick Capital Management first reported a position in ARK Genomic Revolution ETF in Q4 2024 and has held it in 7 quarters since.
  • 272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.